Thursday - October 24, 2024
Ropes & Gray Advises SK Biopharmaceuticals in Worldwide License Agreement With Full-Life Technologies for Radiotherapy Targeting Cancer Cells
September 17, 2024
BOSTON, Massachusetts, Sept. 17 -- Ropes and Gray, a law firm, issued the following news:

Ropes & Gray advised South Korean biotechnology company SK Biopharmaceuticals in a in a global licensing agreement with radiotherapy company Full-Life Technologies for exclusive worldwide clinical research, development, manufacturing and commercialization rights to Full-Life's FL-091 radiopharmaceutical compound designed to deliver targeted radiation therapy to a certain receptor protein wh . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products